This is a StreetInsider.com Premium Only Page

(VIRI) – StreetInsider.com Reports

Mar 26, 2024 09:16 AM Virios Therapeutics (VIRI) Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

Feb 28, 2024 09:16 AM Virios Therapeutics (VIRI) Issues Shareholder Letter

Feb 27, 2024 04:29 PM Virios Therapeutics (VIRI) Announces 10% Salary Cut Across Company

Jan 2, 2024 07:05 AM Virios Therapeutics (VIRI) Reaches Alignment with FDA on Requirements for Advancing IMC-2 for Long-COVID

Nov 13, 2023 07:09 AM Virios Therapeutics (VIRI) Tops Q3 EPS by 3c

Sep 18, 2023 07:05 AM Virios Therapeutics (VIRI) Announces Termination of At-The-Market Sales Agreement

Aug 14, 2023 07:21 AM Virios Therapeutics (VIRI) Halts At-The-Market Offering Sales

Aug 10, 2023 07:05 AM Virios Therapeutics (VIRI) Misses Q2 EPS by 3c

Aug 9, 2023 07:06 AM Virios Therapeutics (VIRI) to Advance IMC-1 to Phase 3 Development

May 11, 2023 07:12 AM Virios Therapeutics (VIRI) Tops Q1 EPS by 8c

Apr 24, 2023 04:15 PM Virios Therapeutics (VIRI) Announces Initial FDA Feedback on Proposed IMC-1 Phase 3 Program

Mar 14, 2023 07:14 AM Virios Therapeutics (VIRI) Tops Q4 EPS by 4c

Feb 13, 2023 07:05 AM Virios Therapeutics (VIRI) Announces Exploratory Long-COVID Trial Top-Line Data Projected in June 2023

Jan 5, 2023 07:04 AM Virios Therapeutics (VIRI) Scheduled FDA Meeting in March 2023 to Discuss IMC-1 Fibromyalgia Phase 3 Program

Nov 14, 2022 07:23 AM Virios Therapeutics (VIRI) Tops Q3 EPS by 18c

Sep 20, 2022 06:57 AM UPDATE: H.C. Wainwright Downgrades Virios Therapeutics (VIRI) to Neutral

Sep 20, 2022 05:51 AM Virios Therapeutics (VIRI) Prices 10M Share Offering at $0.50/sh

Sep 19, 2022 04:05 PM Virios Therapeutics (VIRI) Announces Proposed Stock Offering, Size not Disclosed

Sep 19, 2022 09:19 AM Pre-Open Movers: Wix Gains on Activist Stake, Take-Two Falls on GTA6 Hack

Sep 19, 2022 07:16 AM Virios Therapeutics (VIRI) to Resume Trading at 7:35 a.m.

Sep 19, 2022 07:15 AM Virios Therapeutics (VIRI) Phase 2b Study of IMC-1 in Fibromyalgia Did Not Achieve Statistical Significance

Sep 19, 2022 07:00 AM Virios Therapeutics (VIRI) Halted, News Pending

Sep 19, 2022 04:55 AM Implied Volatility Movement

Sep 13, 2022 05:25 AM Virios Therapeutics (VIRI) 30-day option implied volatility at 314

Sep 12, 2022 02:35 PM Virios Therapeutics (VIRI) 30-day option implied volatility at 311

Sep 12, 2022 04:25 AM Implied Volatility Movement

Sep 9, 2022 05:16 AM Implied Volatility Movement

Sep 7, 2022 04:36 AM Implied Volatility Movement

Sep 2, 2022 02:42 AM Implied Volatility Movement

Aug 31, 2022 04:05 AM Implied Volatility Movement

Aug 11, 2022 07:19 AM Virios Therapeutics (VIRI) Tops Q2 EPS by 7c

Jul 26, 2022 08:33 AM Virios Therapeutics (VIRI) Advances Fibromyalgia Treatment

Jul 19, 2022 08:33 AM Virios Therapeutics (VIRI) Expects Fibromyalgia Phase 2b Results in September 2022

Jun 1, 2022 07:05 AM Virios Therapeutics (VIRI) Featured in Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders

Mar 18, 2022 04:14 PM Virios Therapeutics (VIRI) Files $150M Mixed Shelf

Mar 17, 2022 07:07 AM Virios Therapeutics (VIRI) Reports Q4 Results, Provides Corporate Update

Feb 28, 2022 07:05 AM Virios Therapeutics (VIRI) Enters Research Collaboration for Potential of Combination Antiviral Therapy for Treating Long COVID

Dec 15, 2021 06:11 AM H.C. Wainwright Starts Virios Therapeutics (VIRI) at Buy

Nov 11, 2021 07:07 AM Virios Therapeutics (VIRI) Tops Q3 EPS by 20c; Reports Cash Position of $19.2M

Sep 8, 2021 07:07 AM Virios Therapeutics (VIRI) Granted New Patent for Antiviral Inhibitor Combination

Aug 12, 2021 07:22 AM Virios Therapeutics (VIRI) Reports Q2 Loss of $0.51/sh

Jun 9, 2021 07:34 AM UPDATE: Virios Therapeutics (VIRI) Presents Safetfy Data from Phase 2a Clinical Trial PRID-201 on IMC-1 in Patients with Fibromyalgia

Jun 2, 2021 07:22 AM Virios Therapeutics (VIRI) Presents Phase 2a Fibromyalgia Trial Data on Efficacy Analyses of Key Secondary Endpoints at the EULAR European Congress of Rheumatology

May 13, 2021 07:10 AM Virios Therapeutics (VIRI) Reports Q1 Loss of $0.37

Mar 18, 2021 07:06 AM Virios Therapeutics (VIRI) Reports Q4 Loss of $1.25/sh

Dec 17, 2020 10:51 AM Virios Therapeutics (VIRI) IPO Opens 22% Higher

Dec 17, 2020 06:12 AM Virios Therapeutics, Inc. (VIRI) Prices 3M Share IPO at $10/Sh